REFERENCES
1. Bushby K, Finkel R, Birnkrant DJ, et al. DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010;9:177-89.
2. Radley-Crabb HG, Marini JC, Sosa HA, Castillo LI, Grounds MD, Fiorotto ML. Dystropathology increases energy expenditure and protein turnover in the mdx mouse model of duchenne muscular dystrophy. PLoS One. 2014;9:e89277.
3. Brooke MH, Fenichel GM, Griggs RC, et al. Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology. 1989;39:475-81.
4. Sutherland DH, Olshen R, Cooper L, et al. The pathomechanics of gait in Duchenne muscular dystrophy. Dev Med Child Neurol. 1981;23:3-22.
5. McDonald CM, Henricson EK, Han JJ, et al. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve. 2010;41:500-10.
6. McDonald CM, Henricson EK, Abresch RT, et al. CINRG Investigators. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. Lancet. 2018;391:451-61.
7. Markati T, Oskoui M, Farrar MA, Duong T, Goemans N, Servais L. Emerging therapies for Duchenne muscular dystrophy. Lancet Neurol. 2022;21:814-29.
8. Johnson LM, Pulskamp TG, Berlau DJ. The latest developments in synthetic approaches to Duchenne muscular dystrophy. Expert Rev Neurother. 2025;4:1-11.
9. Haque US, Yokota T. Gene editing for Duchenne muscular dystrophy: from experimental models to emerging therapies. Degener Neurol Neuromuscul Dis. 2025;15:17-40.
10. Gaudreault N, Gravel D, Nadeau S, Houde S, Gagnon D. Gait patterns comparison of children with Duchenne muscular dystrophy to those of control subjects considering the effect of gait velocity. Gait Posture. 2010;32:342-7.
11. Buckon CE, Sienko SE, Fowler EG, et al. A longitudinal study of quantitative muscle strength and functional motor ability in ambulatory boys with Duchenne muscular dystrophy. J Neuromuscul Dis. 2022;9:321-34.
12. Sienko S, Buckon C, Bagley A, et al. Kinematic changes in gait in boys with Duchenne muscular dystrophy: utility of the gait deviation index, the gait profile score and the gait variable scores. Gait Posture. 2023;100:157-64.
13. Norkin CC, White DJ. Measurement of joint motion: a guide to goniometry. 4th ed. Philadelphia: F A Davis Company; 2016. Available from: https://books.google.com/books?id=TSluDQAAQBAJ&dq=13.+Norkin+CC,+White+DJ.+Measurement+of+joint+motion:+a+guide+to+goniometry.+4th+ed.+Philadelphia:+F+A+Davis+Company,+2009.&lr=&hl=zh-CN&source=gbs_navlinks_s [Last accessed on 1 July 2025].
14. Mudge AJ, Bau KV, Purcell LN, et al. Normative reference values for lower limb joint range, bone torsion, and alignment in children aged 4-16 years. J Pediatr Orthop B. 2014;23:15-25.
15. Liyanarachi S, Hulleberg G, Foss OA. Is gastrocnemius tightness a normal finding in children? J Bone Joint Surg Am. 2021;103:1872-9.
16. Scott OM, Hyde SA, Goddard C, Dubowitz V. Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve. 1982;5:291-301.
17. McDonald CM, Abresch RT, Carter GT, et al. Profiles of neuromuscular diseases: Duchenne muscular dystrophy. Am J Phys Med Rehabil. 1995;74:S70-92.
18. Davis RB, Õunpuu S, Tyburski D, Gage JR. A gait analysis data collection and reduction technique. Human Movement Science. 1991;10:575-87.
19. Baker R, McGinley JL, Schwartz MH, et al. The gait profile score and movement analysis profile. Gait Posture. 2009;30:265-9.
21. Hoffman L. Longitudinal analysis: modeling within-person fluctuation and change. 1th ed. Routledge; 2014. Available from: https://www.taylorfrancis.com/books/mono/10.4324/9781315744094/longitudinal-analysis-lesa-hoffman [Last accessed on 1 July 2025].
22. Curran PJ, Obeidat K, Losardo D. Twelve frequently asked questions about growth curve modeling. J Cogn Dev. 2010;11:121-36.
23. Bauer DJ, Curran PJ. Probing interactions in fixed and multilevel regression: inferential and graphical techniques. Multivariate Behav Res. 2005;40:373-400.
24. Hox J, Moerbeek M, van de Schoot R. Multilevel Analysis: Techniques and Applications. 3th ed. New York: Routledge; 2017.
25. Choi YA, Chun SM, Kim Y, Shin HI. Lower extremity joint contracture according to ambulatory status in children with Duchenne muscular dystrophy. BMC Musculoskelet Disord. 2018;19:287.
26. Willcocks RJ, Barnard AM, Wortman RJ, et al. Development of contractures in DMD in Relation to MRI-determined muscle quality and ambulatory function. J Neuromuscul Dis. 2022;9:289-302.
27. Skalsky AJ, McDonald CM. Prevention and management of limb contractures in neuromuscular diseases. Phys Med Rehabil Clin N Am. 2012;23:675-87.
28. Perry J. Gait analysis: normal and pathological function. 1th ed. CRC Press; 1992. Available from: https://archive.org/details/gaitanalysisnorm0000perr/mode/2up [Last accessed on 1 July 2025].
29. Hsu JD, Furumasu J. Gait and posture changes in the Duchenne muscular dystrophy child. Clin Orthop Relat Res. 1993;288:155-5. Available from: https://journals.lww.com/corr/abstract/1993/03000/gait_and_posture_changes_in_the_duchenne_muscular.15.aspx [Last accessed on 1 July 2025].
30. D’Angelo MG, Berti M, Piccinini L, et al. Gait pattern in Duchenne muscular dystrophy. Gait Posture. 2009;29:36-41.
31. Heberer K, Fowler E, Staudt L, et al. Hip kinetics during gait are clinically meaningful outcomes in young boys with Duchenne muscular dystrophy. Gait Posture. 2016;48:159-64.
32. Duffy CM, Hill AE, Cosgrove AP, Corry IS, Mollan RA, Graham HK. Three-dimensional gait analysis in spina bifida. J Pediatr Orthop. 1996;16:786-91.
33. Fusagawa H, Fujita H, Matsuyama T, et al. Gait profile score and gait variable scores in spina bifida. J Pediatr Orthop B. 2022;31:e251-7.
34. Katz K, Rosenthal A, Yosipovitch Z. Normal ranges of popliteal angle in children. J Pediatr Orthop. 1992;12:229-31.
35. Goudriaan M, Huenaerts C, Hauwe MVd, Molenaers G, Goemans N, Desloovere K. Gait deviations in children with Duchenne muscular dystrophy can be directly attributed to muscle weakness in two lower limb muscle groups. Gait Posture. 2017;57:38-39.
36. Duong T, Canbek J, Fernandez-Fernandez A, et al. CINRG Investigators. Knee strength and ankle range of motion impacts on timed function tests in Duchenne muscular dystrophy: in the era of glucocorticoids. J Neuromuscul Dis. 2022;9:147-59.
37. Gaudreault N, Gravel D, Nadeau S, Desjardins P, Brière A. A method to evaluate contractures effects during the gait of children with Duchenne dystrophy. Clin Orthop Relat Res. 2007;456:51-7.
38. Goudriaan M, Van den Hauwe M, Dekeerle J, et al. Gait deviations in Duchenne muscular dystrophy-Part 1. A systematic review. Gait Posture. 2018;62:247-61.
39. Norlin R, Odenrick P, Sandlund B. Development of gait in the normal child. J Pediatr Orthop. 1981;1:261-6.
40. Lim KRQ, Nguyen Q, Yokota T. Genotype-phenotype correlations in Duchenne and becker muscular dystrophy patients from the Canadian neuromuscular disease registry. J Pers Med. 2020;10:241.
41. Sienko S, Buckon CE, Bagley A, et al. Longitudinal changes in energy cost during walking in boys with Duchenne muscular dystrophy (DMD). Gait Posture. 2021;90:301-6.
42. Sankar WN, Laird CT, Baldwin KD. Hip range of motion in children: what is the norm? J Pediatr Orthop. 2012;32:399-405.
